全文获取类型
收费全文 | 20515篇 |
免费 | 2854篇 |
国内免费 | 400篇 |
专业分类
耳鼻咽喉 | 143篇 |
儿科学 | 1083篇 |
妇产科学 | 597篇 |
基础医学 | 1971篇 |
口腔科学 | 225篇 |
临床医学 | 2556篇 |
内科学 | 5662篇 |
皮肤病学 | 387篇 |
神经病学 | 1580篇 |
特种医学 | 357篇 |
外科学 | 2470篇 |
综合类 | 1387篇 |
现状与发展 | 1篇 |
一般理论 | 6篇 |
预防医学 | 2166篇 |
眼科学 | 744篇 |
药学 | 931篇 |
2篇 | |
中国医学 | 352篇 |
肿瘤学 | 1149篇 |
出版年
2024年 | 59篇 |
2023年 | 451篇 |
2022年 | 264篇 |
2021年 | 487篇 |
2020年 | 462篇 |
2019年 | 225篇 |
2018年 | 804篇 |
2017年 | 796篇 |
2016年 | 871篇 |
2015年 | 841篇 |
2014年 | 757篇 |
2013年 | 1047篇 |
2012年 | 1437篇 |
2011年 | 1515篇 |
2010年 | 981篇 |
2009年 | 944篇 |
2008年 | 1140篇 |
2007年 | 1171篇 |
2006年 | 939篇 |
2005年 | 1060篇 |
2004年 | 1489篇 |
2003年 | 1310篇 |
2002年 | 990篇 |
2001年 | 860篇 |
2000年 | 351篇 |
1999年 | 359篇 |
1998年 | 389篇 |
1997年 | 312篇 |
1996年 | 164篇 |
1995年 | 112篇 |
1994年 | 100篇 |
1993年 | 119篇 |
1992年 | 103篇 |
1991年 | 61篇 |
1990年 | 67篇 |
1989年 | 63篇 |
1988年 | 65篇 |
1987年 | 52篇 |
1986年 | 49篇 |
1985年 | 24篇 |
1984年 | 26篇 |
1983年 | 26篇 |
1982年 | 24篇 |
1981年 | 26篇 |
1980年 | 25篇 |
1979年 | 21篇 |
1978年 | 17篇 |
1977年 | 18篇 |
1974年 | 23篇 |
1968年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
972.
S. Dhami S. S. Panesar G. Roberts A. Muraro M. Worm M. B. Bilò V. Cardona A. E. J. Dubois A. DunnGalvin P. Eigenmann M. Fernandez‐Rivas S. Halken G. Lack B. Niggemann F. Rueff A. F. Santos B. Vlieg‐Boerstra Z. Q. Zolkipli A. Sheikh the EAACI Food Allergy Anaphylaxis Guidelines Group 《Allergy》2014,69(2):168-175
To establish the effectiveness of interventions for the acute and long‐term management of anaphylaxis, seven databases were searched for systematic reviews, randomized controlled trials, quasi‐randomized controlled trials, controlled clinical trials, controlled before–after studies and interrupted time series and – only in relation to adrenaline – case series investigating the effectiveness of interventions in managing anaphylaxis. Fifty‐five studies satisfied the inclusion criteria. We found no robust studies investigating the effectiveness of adrenaline (epinephrine), H1‐antihistamines, systemic glucocorticosteroids or methylxanthines to manage anaphylaxis. There was evidence regarding the optimum route, site and dose of administration of adrenaline from trials studying people with a history of anaphylaxis. This suggested that administration of intramuscular adrenaline into the middle of vastus lateralis muscle is the optimum treatment. Furthermore, fatality register studies have suggested that a failure or delay in administration of adrenaline may increase the risk of death. The main long‐term management interventions studied were anaphylaxis management plans and allergen‐specific immunotherapy. Management plans may reduce the risk of further reactions, but these studies were at high risk of bias. Venom immunotherapy may reduce the incidence of systemic reactions in those with a history of venom‐triggered anaphylaxis. 相似文献
973.
T. Holzhauser L. K. Poulsen M. H. Gowland C. A. Akdis E. N. C. Mills N. Papadopoulos G. Roberts S. Schnadt R. van Ree A. Sheikh S. Vieths the EAACI Food Allergy Anaphylaxis Guidelines Group 《Allergy》2014,69(11):1464-1472
Individuals suffering from IgE‐mediated food allergy usually have to practise life‐long food allergen avoidance. This document aims to provide an overview of recent evidence‐based recommendations for allergen risk assessment and management in the food industry and discusses unmet needs and expectations of the food allergic consumer in that context. There is a general duty of care on the food industry and obligations in European Union legislation to reduce and manage the presence of allergens alongside other food hazards. Current evidence enables quantification of allergen reference doses used to set‐up reliable food safety management plans for some foods. However, further work is required to include a wider variety of foods and to understand the impact of the food matrix as well as additional factors which affect the progression and severity of symptoms as a function of dose. Major concerns have been raised by patients, carers and patient groups about the use of precautionary ‘may contain’ labelling to address the issue of unintended presence of allergens; these therefore need to be reconsidered. New and improved allergen detection methods should be evaluated for their application in food production. There is an urgent requirement for effective communication between healthcare professionals, patient organizations, food industry representatives and regulators to develop a better approach to protecting consumers with food allergies. 相似文献
974.
G. Roberts K. Beyer C. Bindslev‐Jensen V. Cardona A. Dubois G. duToit P. Eigenmann M. Fernandez Rivas S. Halken L. Hickstein A. Høst E. Knol G. Lack M. J. Marchisotto B. Niggemann B. I. Nwaru N. G. Papadopoulos L. K. Poulsen A. F. Santos I. Skypala A. Schoepfer R. Van Ree C. Venter M. Worm B. Vlieg–Boerstra S. Panesar D. de Silva K. Soares‐Weiser A. Sheikh B. K. Ballmer‐Weber C. Nilsson N. W. de Jong C. A. Akdis the EAACI Food Allergy Anaphylaxis Guidelines Group 《Allergy》2014,69(8):1008-1025
Food allergy can result in considerable morbidity, impact negatively on quality of life, and prove costly in terms of medical care. These guidelines have been prepared by the European Academy of Allergy and Clinical Immunology's (EAACI) Guidelines for Food Allergy and Anaphylaxis Group, building on previous EAACI position papers on adverse reaction to foods and three recent systematic reviews on the epidemiology, diagnosis, and management of food allergy, and provide evidence‐based recommendations for the diagnosis and management of food allergy. While the primary audience is allergists, this document is relevant for all other healthcare professionals, including primary care physicians, and pediatric and adult specialists, dieticians, pharmacists and paramedics. Our current understanding of the manifestations of food allergy, the role of diagnostic tests, and the effective management of patients of all ages with food allergy is presented. The acute management of non‐life‐threatening reactions is covered in these guidelines, but for guidance on the emergency management of anaphylaxis, readers are referred to the related EAACI Anaphylaxis Guidelines. 相似文献
975.
Jill J. Francis Eilidh M. Duncan Maria E. Prior Graeme MacLennan Andrea P. Marshall Elisabeth C. Wells Laura Todd Louise Rose Marion K. Campbell Fiona Webster Martin P. Eccles Geoff Bellingan Ian M. Seppelt Jeremy M. Grimshaw Brian H. Cuthbertson for the SuDDICU study groups 《British journal of health psychology》2014,19(2):274-291
976.
Mary M. Jenkins Jennita Reefhuis Margaret L. Gallagher Jennifer G. Mulle Thomas J. Hoffmann Deborah A. Koontz Cynthia Sturchio Sonja A. Rasmussen John S. Witte Patricia Richter Margaret A. Honein the National Birth Defects Prevention Study 《American journal of medical genetics. Part A》2014,164(6):1454-1463
977.
978.
979.